{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:40:52Z","timestamp":1787168452249,"version":"build-2736575974"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jpba.2022.114987","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T21:49:37Z","timestamp":1659995377000},"page":"114987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Recent challenges and trends in forensic analysis: \u03949-THC isomers pharmacology, toxicology and analysis"],"prefix":"10.1016","volume":"220","author":[{"given":"Nunzia","family":"La Maida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Di Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Busard\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn A.","family":"Huestis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2022.114987_bib1","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jpba.2022.114987_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0006-2952(74)90435-3","article-title":"Relative pharmacological potency in mice of optical isomers of \u03941-tetrahydrocannabinol","volume":"23","author":"Jones","year":"1974","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpba.2022.114987_bib3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1021\/jm00241a012","article-title":"Analgesic properties of the tetrahydrocannabinols, their metabolites, and analogs","volume":"18","author":"Wilson","year":"1975","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2022.114987_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0006-8993(80)90078-5","article-title":"Reduction of hippocampal acetylcholine turnover in rats treated with (-)-delta 8-tetrahydrocannabinol and its 1\u2032,2\u2032-dimethyl-heptyl homolog","volume":"195","author":"Revuelta","year":"1980","journal-title":"Brain Res."},{"key":"10.1016\/j.jpba.2022.114987_bib5","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1021\/ja00960a056","article-title":"Isolation of trans-\u0394 6 -Tetrahydrocannabinol from Marijuana","volume":"88","author":"Hively","year":"1966","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jpba.2022.114987_bib6","unstructured":"Agriculture Improvement Act of 2018. H.R.2 115th Congress (2017\u20132018), n.d. \u3008https:\/\/www.congress.gov\/bill\/115th-congress\/house-bill\/2?q=%7B%22search%22%3A%5B%22hr2+115\u2013334%22%2C%22hr2%22%2C%22115\u2013334%22%5D%7D&s=4&r=1\u3009."},{"key":"10.1016\/j.jpba.2022.114987_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/toxics8020041","article-title":"Conversion of Cannabidiol (CBD) into psychotropic cannabinoids including tetrahydrocannabinol (THC): a controversy in the scientific literature","volume":"8","author":"Golombek","year":"2020","journal-title":"Toxics"},{"key":"10.1016\/j.jpba.2022.114987_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103557","article-title":"Public interest in \u22068-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted \u22069-Tetrahydrocannabinol (delta-9-THC) use","volume":"101","author":"Leas","year":"2022","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.jpba.2022.114987_bib9","unstructured":"G.B. Dawson, B. Njau, S. Rana, Detection of delta-8-tHC-CooH in urine samples and its implications in workplace drug testing., 57th Annu. Meet. Int. Assoc. Forensic Toxicol. Programme Abstr. (2019)."},{"key":"10.1016\/j.jpba.2022.114987_bib10","unstructured":"Drug Enforcement AdministrationImplementation of the Agriculture Improvement Act of 2018 Fed. Regist. 2020.\u3008https:\/\/www.federalregister.gov\/documents\/2020\/08\/21\/2020-17356\/implementation-of-the-agriculture-improvement-act-of-2018\u3009."},{"key":"10.1016\/j.jpba.2022.114987_bib11","unstructured":"Office of the Commissioner, FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD), FDA. (2021). \u3008https:\/\/www.fda.gov\/news-events\/public-health-focus\/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd\u3009."},{"key":"10.1016\/j.jpba.2022.114987_bib12","unstructured":"Office of the Commissioner, Warning Letters and Test Results for Cannabidiol-Related Products, FDA. (2022). \u3008https:\/\/www.fda.gov\/news-events\/public-health-focus\/warning-letters-and-test-results-cannabidiol-related-products\u3009."},{"key":"10.1016\/j.jpba.2022.114987_bib13","unstructured":"Office of the Commissioner, 5 Things to Know about Delta-8 Tetrahydrocannabinol \u2013 Delta-8 THC, FDA. (2022). \u3008https:\/\/www.fda.gov\/consumers\/consumer-updates\/5-things-know-about-delta-8-tetrahydrocannabinol-delta-8-thc\u3009."},{"key":"10.1016\/j.jpba.2022.114987_bib14","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1111\/bph.15865","article-title":"Review of delta-8-tetrahydrocannabinol (\u03948-THC): comparative pharmacology with \u03949-THC","volume":"179","author":"Tagen","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpba.2022.114987_bib15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.lfs.2012.08.023","article-title":"Brain regional differences in CB1 receptor adaptation and regulation of transcription","volume":"92","author":"Lazenka","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.jpba.2022.114987_bib16","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2165\/11591430-000000000-00000","article-title":"Cannabis in sport: anti-doping perspective","volume":"41","author":"Huestis","year":"2011","journal-title":"Sports Med. Auckl. Nz."},{"key":"10.1016\/j.jpba.2022.114987_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2826.2008.01671.x","article-title":"Cannabinoid receptors: where they are and what they do","volume":"20","author":"Mackie","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.jpba.2022.114987_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0083-6729(09)81007-8","article-title":"Chapter 7 cannabinoid receptor CB1 antagonists","author":"Bifulco","year":"2009","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.jpba.2022.114987_bib19","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399409000957","article-title":"Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation","volume":"11","author":"Cabral","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.jpba.2022.114987_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bjp.0707505","article-title":"Cannabinoid CB2 receptors in human brain inflammation","volume":"153","author":"Benito","year":"2008","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.jpba.2022.114987_bib21","first-page":"83","article-title":"Inflammation in Parkinson\u2019s disease","volume":"86","author":"McGeer","year":"2001","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.jpba.2022.114987_bib22","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.42.2.447","article-title":"Anti\u2010inflammatory agents as a therapeutic approach to Alzheimer\u2019s disease","volume":"42","author":"McGeer","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.jpba.2022.114987_bib23","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1016\/S0968-0896(03)00238-4","article-title":"Synthesis and testing of novel classical cannabinoids: exploring the side chain ligand binding pocket of the CB1 and CB2 receptors","volume":"11","author":"Nadipuram","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jpba.2022.114987_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejps.2004.07.013","article-title":"Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors","volume":"23","author":"Govaerts","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2022.114987_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0304-3940(96)13233-X","article-title":"Characterisation of the rat cerebella CB1 receptor using SR141716A, a central cannabinoid receptor antagonist","volume":"220","author":"Hirst","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpba.2022.114987_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0091-3057(93)90356-X","article-title":"Pharmacological evaluation of iodo and nitro analogs of \u03948-THC and \u03949-THC","volume":"46","author":"Martin","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jpba.2022.114987_bib27","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1016\/S0968-0896(99)00219-9","article-title":"3-(1\u2032,1\u2032-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor","volume":"7","author":"Huffman","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jpba.2022.114987_bib28","first-page":"4295","article-title":"Evaluation of phytocannabinoids from high potency cannabis sativa using in vitro bioassays to determine structure-activity relationships for cannabinoid receptor 1 and cannabinoid receptor 2","volume":"23","author":"Husni","year":"2014","journal-title":"Med. Chem. Res. Int. J. Rapid Commun. Des. Mech. Action Biol. Act. Agents"},{"key":"10.1016\/j.jpba.2022.114987_bib29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0031-9384(69)90149-8","article-title":"A neuropharmacological investigation of some trans-tetrahydrocannabinol derivatives","volume":"4","author":"Lipparini","year":"1969","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.jpba.2022.114987_bib30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/BF00404218","article-title":"Psychopharmacological activity of the active constituents of hashish and some related cannabinoids","volume":"14","author":"Grunfeld","year":"1969","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.jpba.2022.114987_bib31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0041-008X(73)90310-4","article-title":"Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys","volume":"25","author":"Thompson","year":"1973","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jpba.2022.114987_bib32","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/2261265a0","article-title":"Pharmacology of some marijuana constituents and 2 heterocyclic analogues","volume":"226","author":"Dewey","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.jpba.2022.114987_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000136375","article-title":"Comparative studies in man and in laboratory animals on 8 - and 9 -trans-tetrahydrocannabinol","volume":"9","author":"Karniol","year":"1973","journal-title":"Pharmacology"},{"key":"10.1016\/j.jpba.2022.114987_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1021\/jm00236a025","article-title":"Hashish. Importance of the phenolic hydroxyl group in tetrahydrocannabinols","volume":"18","author":"Uliss","year":"1975","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2022.114987_bib35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pbb.2010.03.004","article-title":"Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L","volume":"95","author":"El-Alfy","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jpba.2022.114987_bib36","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1021\/jm00115a023","article-title":"Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol","volume":"34","author":"Compton","year":"1991","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2022.114987_bib37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0091-3057(93)90356-X","article-title":"Pharmacological evaluation of iodo and nitro analogs of delta 8-THC and delta 9-THC","volume":"46","author":"Martin","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jpba.2022.114987_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0091-3057(74)90057-4","article-title":"Anticonvulsant activity of delta-8- and delta-9-tetrahydrocannabinol in rats","volume":"2","author":"McCaughran","year":"1974","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jpba.2022.114987_bib39","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0091-3057(75)90116-1","article-title":"Marihuana-like activity of new synthetic tetrahydrocannabinols","volume":"3","author":"Martin","year":"1975","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jpba.2022.114987_bib40","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1248\/cpb.38.2317","article-title":"Comparison of pharmacological effects of tetrahydrocannabinols and their 11-hydroxy-metabolites in mice","volume":"38","author":"Watanabe","year":"1990","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jpba.2022.114987_bib41","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1476-5381.1973.tb08534.x","article-title":"The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice","volume":"49","author":"Chesher","year":"1973","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpba.2022.114987_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/can.2017.0041","article-title":"The cannabinoids \u03948THC, CBD, and HU-308 act via distinct receptors to reduce corneal pain and inflammation","volume":"3","author":"Thapa","year":"2018","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.jpba.2022.114987_bib43","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0041-008X(75)90268-9","article-title":"Anticonvulsant activities of delta-8 and delta-9 tetrahydrocannabinol and uridine","volume":"31","author":"Dwivedi","year":"1975","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jpba.2022.114987_bib44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejphar.2007.01.093","article-title":"Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew","volume":"563","author":"Darmani","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpba.2022.114987_bib45","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/0024-3205(73)90124-0","article-title":"Hypothermic action of delta 9-tetrahydrocannabinol, 11-hydroxy-delta 9-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice","volume":"13","author":"Haavik","year":"1973","journal-title":"Life Sci."},{"key":"10.1016\/j.jpba.2022.114987_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(80)90110-7","article-title":"Comparison in mice of pharmacological effects of delta 8-tetrahydrocannabinol and its metabolites oxidized at 11-position","volume":"63","author":"Watanabe","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpba.2022.114987_bib47","article-title":"Synthesis and pharmacological activity of a phosphate ester of.DELTA.8-tetrahydrocannabinol","author":"Yoshimura","year":"2002","journal-title":"ACS Publ."},{"key":"10.1016\/j.jpba.2022.114987_bib48","first-page":"558","article-title":"9 alpha, 10 alpha-epoxyhexahydrocannabinol formation from delta 9-tetrahydrocannabinol by liver microsomes of phenobarbital-treated mice and its pharmacological activities in mice","volume":"6","author":"Narimatsu","year":"1983","journal-title":"J. Pharm."},{"key":"10.1016\/j.jpba.2022.114987_bib49","first-page":"133","article-title":"Some pharmacological and toxicological effects of 1-trans- 8 and 1-trans- 9 -tetrahydrocannabinol in laboratory rodents","volume":"196","author":"Dewey","year":"1972","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.jpba.2022.114987_bib50","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/cpt1973143353","article-title":"Delta-8- and delta-9-tetrahydrocannabinol comparison in man by oral and intravenous administration","volume":"14","author":"Hollister","year":"1973","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2022.114987_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000136462","article-title":"Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of delta9-tetrahydrocannabinol","volume":"11","author":"Hollister","year":"1974","journal-title":"Pharmacology"},{"key":"10.1016\/j.jpba.2022.114987_bib52","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1021\/ja00960a056","article-title":"Isolation of trans \u03946-Tetrahydrocannabinol from Marijuana","author":"Hively","year":"1966","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jpba.2022.114987_bib53","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1080\/01483918708066836","article-title":"Separation of tetrahydrocannabinol isomers by reverse-phase high pressure liquid chromatography","volume":"10","author":"Banijamali","year":"1987","journal-title":"J. Liq. Chromatogr."},{"key":"10.1016\/j.jpba.2022.114987_bib54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0021-9673(00)89021-4","article-title":"High-Pressure liquid chromatography of cannabis identification of separated constituents","volume":"115","author":"Smith","year":"1975","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2022.114987_bib55","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jhrc.1240020304","article-title":"High performance liquid chromatography with electrochemical detection 1: separation of cannabis constituents and quantitationof A9Tetrahydrocannabino1","author":"Masoud","year":"1979","journal-title":"J. High. Resolut. Chromatogr. Chromatogr. Commun."},{"key":"10.1016\/j.jpba.2022.114987_bib56","unstructured":"T. Tarbox, I. Dilek, U. Sreenivasan, K. Yaser, A Validated Chiral HPLC Method for Resolution of \u03948 and \u03949-tetrahydrocannabinol Enantiomers, Cerilliant Poster. (2009)."},{"key":"10.1016\/j.jpba.2022.114987_bib57","doi-asserted-by":"crossref","unstructured":"B. De Backer, B. Debrus, P. Lebrun, L. Theunis, N. Dubois, L. Decock, A. Verstraete, P. Hubert, C. Charlier, Innovative development and validation of an HPLC\/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material, J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci. 877 (2009) 4115\u20134124. https:\/\/doi.org\/10.1016\/j.jchromb.2009.11.004.","DOI":"10.1016\/j.jchromb.2009.11.004"},{"key":"10.1016\/j.jpba.2022.114987_bib58","first-page":"119","article-title":"Identification and characterization of special types of herbal cannabis","volume":"74","author":"Trofin","year":"2012","journal-title":"UPB Sci. Bull. Ser. B Chem. Mater. Sci."},{"key":"10.1016\/j.jpba.2022.114987_bib59","article-title":"The separation of \u22068 -THC, \u22069-THC, and their enantiomers by UPC2 using trefoil chiral columns","author":"Runco","year":"2016","journal-title":"Appl. Note"},{"key":"10.1016\/j.jpba.2022.114987_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-9872.1000349","article-title":"Classification of cannabis cultivars marketed in canada for medical purposes by quantification of cannabinoids and terpenes using HPLC-DAD and GC-MS","volume":"08","author":"Jin","year":"2017","journal-title":"J. Anal. Bioanal. Tech."},{"key":"10.1016\/j.jpba.2022.114987_bib61","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jssc.201700946","article-title":"Determination of cannabinoids from a surrogate hops matrix using multiple reaction monitoring gas chromatography with triple quadrupole mass spectrometry","volume":"41","author":"Leghissa","year":"2018","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2022.114987_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jpba.2017.07.021","article-title":"Qualitative and quantitative measurement of cannabinoids in cannabis using modified HPLC\/DAD method","volume":"146","author":"Patel","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.114987_bib63","unstructured":"Restek Application Note, 16 Cannabinoids on Raptor ARC-18 2.7 \u03bcm by LC-UV, Restek. (2017)."},{"key":"10.1016\/j.jpba.2022.114987_bib64","unstructured":"SigmaAldrich Application Note, Rapid and Comprehensive Analysis of Cannabinoid Potency by HPLC \/ UV using the Ascentis \u00ae Express C18 Column, (2017)."},{"key":"10.1016\/j.jpba.2022.114987_bib65","article-title":"Very fast RP\u2013UHPLC\u2013PDA method for identification and quantification of the cannabinoids from hemp oil","volume":"11","author":"Blebea","year":"2021","journal-title":"Appl. Sci. Switz."},{"key":"10.1016\/j.jpba.2022.114987_bib66","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jfda.2018.06.001","article-title":"Development and validation of a Fast gas chromatography\/mass spectrometry method for the determination of cannabinoids in Cannabis sativa L","volume":"26","author":"Cardenia","year":"2018","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.jpba.2022.114987_bib67","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/rcm.8242","article-title":"A rapid method to determine nine natural cannabinoids in beverages and food derived from Cannabis sativa by liquid chromatography coupled to tandem mass spectrometry on a QTRAP 4000","volume":"32","author":"Di Marco Pisciottano","year":"2018","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2022.114987_bib68","unstructured":"SHIMADZU APPLICATION NOTE, The Potency Determination of 16 Cannabinoids, (2018)."},{"key":"10.1016\/j.jpba.2022.114987_bib69","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-0043-124873","article-title":"Quantitative determination of \u0394 9 -THC, CBG, CBD, their acid precursors and five other neutral cannabinoids by UHPLC-UV-MS","volume":"84","author":"Wang","year":"2018","journal-title":"Planta Med"},{"key":"10.1016\/j.jpba.2022.114987_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpls.2019.00120","article-title":"Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry","volume":"10","author":"Citti","year":"2019","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.jpba.2022.114987_bib71","article-title":"Untargeted characterization of extracts from Cannabis sativa L. cultivars by gas and liquid chromatography coupled to mass spectrometry in high resolution mode","volume":"208","author":"Delgado-Povedano","year":"2019","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2022.114987_bib72","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00217-019-03344-7","article-title":"A simplified approach for isocratic HPLC analysis of cannabinoids by fine tuning chromatographic selectivity","volume":"246","author":"Kri\u017eman","year":"2020","journal-title":"Eur. Food Res. Technol."},{"key":"10.1016\/j.jpba.2022.114987_bib73","first-page":"1","author":"Mandrioli","year":"2019","journal-title":"Method Cannabis Sativa L"},{"key":"10.1016\/j.jpba.2022.114987_bib74","unstructured":"W.M. Reuter, High Speed Chromatographic Analysis of 16 Cannabinoids by HPLC-PDA, PerkinElmer Appl. Note. (n.d.) 1\u20134."},{"key":"10.1016\/j.jpba.2022.114987_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.126469","article-title":"Development, validation and application of a LC-MS\/MS method for quantification of 15 cannabinoids in food","volume":"318","author":"Christinat","year":"2020","journal-title":"Food Chem."},{"key":"10.1016\/j.jpba.2022.114987_bib76","first-page":"18","article-title":"Rapid analysis of 16 major and minor cannabinoids in hemp using LC\u2013MS\/MS with a single sample dilution and injection, cannabis","volume":"3","author":"Dalmia","year":"2020","journal-title":"Sci. Technol."},{"key":"10.1016\/j.jpba.2022.114987_bib77","unstructured":"B.C. Duffy, L. Li, S. Lu, M.A. Dittmar, E. Delaney-Baldwin, L.A. Durocher, D.C. Spink, Chemotyping of \u22068-THC-Containing e-Liquids Analyzed during the 2019\u20132020 New York State EVALI Investigation, (n.d.) 7."},{"key":"10.1016\/j.jpba.2022.114987_bib78","first-page":"1","article-title":"16 cannabinoids for potency testing by practical LC-UV","author":"Krepich","year":"2019","journal-title":"Phenom. Appl. Note"},{"key":"10.1016\/j.jpba.2022.114987_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114344","article-title":"CBD oils on the Belgian market: a validated MRM GC-MS\/MS method for routine quality control using QuEChERS sample clean up","volume":"205","author":"Duchateau","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.114987_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biology10060481","article-title":"Development and optimization of supercritical fluid extraction setup leading to quantification of 11 cannabinoids derived from medicinal cannabis","volume":"10","author":"Qamar","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.jpba.2022.114987_bib81","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1021\/acs.jnatprod.1c00513","article-title":"\u03949-cis-tetrahydrocannabinol: natural occurrence, chirality, and pharmacology","volume":"84","author":"Schafroth","year":"2021","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.jpba.2022.114987_bib82","unstructured":"W. Umstead, The Separation of Several Minor Cannabinoids via Chiral HPLC, Cannabis Sci. Technol. 4 (n.d.) 44\u201350."},{"key":"10.1016\/j.jpba.2022.114987_bib83","article-title":"HPLC method to differentiate four THC stereoisomers formed from \u03949-THC degradation: (6aR,9R)-\u039410-THC, (6aR,9S)-\u039410-THC, 9(R)-\u03946a,10a-THC, and 9(S)-\u03946a,10a-THC","author":"Williams","year":"2021","journal-title":"Cayman Chem."},{"key":"10.1016\/j.jpba.2022.114987_bib84","first-page":"34","article-title":"Gradient HPLC-UV method for cannabinoid profiling","author":"Franklin","year":"2019","journal-title":"Chromatogr. Today"},{"key":"10.1016\/j.jpba.2022.114987_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.talo.2022.100112","article-title":"Quality control of cannabis inflorescence and oil products: response factors for the cost-efficient determination of ten cannabinoids by HPLC","volume":"5","author":"Hall","year":"2022","journal-title":"Talanta Open"},{"key":"10.1016\/j.jpba.2022.114987_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.462953","article-title":"Development of a validated method for rapid quantification of up to sixteen cannabinoids using ultra-high-performance liquid chromatography diode-array detector with optional electrospray ionization time-of-flight mass spectrometry detection","volume":"1670","author":"Song","year":"2022","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2022.114987_bib87","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.forsciint.2018.05.032","article-title":"Commercial cannabis consumer products part 1: GC\u2013MS qualitative analysis of cannabis cannabinoids","volume":"289","author":"Ciolino","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2022.114987_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.746479","article-title":"EVALI vaping liquids part 1: GC-MS Cannabinoids profiles and identification of unnatural THC isomers","volume":"9","author":"Ciolino","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.jpba.2022.114987_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/ph14121250","article-title":"The separation of cannabinoids on Sub-2 \u00b5m immobilized polysaccharide chiral stationary phases","volume":"14","author":"Onishi","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jpba.2022.114987_bib90","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.5740\/jaoacint.15-095","article-title":"Determination of 11 cannabinoids in biomass and extracts of different varieties of cannabis using high-performance liquid chromatography","volume":"98","author":"Gul","year":"2015","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.jpba.2022.114987_bib91","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1081\/JLC-200028170","article-title":"Preparative isolation of cannabinoids from Cannabis sativa by centrifugal partition chromatography","volume":"27","author":"Hazekamp","year":"2004","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2022.114987_bib92","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1021\/acs.chemrestox.1c00388","article-title":"Novel \u03948-tetrahydrocannabinol vaporizers contain unlabeled adulterants, unintended byproducts of chemical synthesis, and heavy metals","volume":"35","author":"Meehan-Atrash","year":"2022","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jpba.2022.114987_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jat\/bkab029","article-title":"Emergence of Delta-8 tetrahydrocannabinol in DUID investigation casework: method development, validation and application","volume":"46","author":"Chan-Hosokawa","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2022.114987_bib94","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpba.2004.11.055","article-title":"LC\u2013MS method for the estimation of \u03948-THC and 11-nor-\u03948-THC-9-COOH in plasma","volume":"38","author":"Valiveti","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.114987_bib95","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jchromb.2019.03.002","article-title":"Development and validation of an assay to measure cannabidiol and \u03949-tetrahydrocannabinol in human EDTA plasma by UHPLC-MS\/MS","volume":"1112","author":"Ocque","year":"2019","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.jpba.2022.114987_bib96","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.933488","article-title":"Sedation and acute encephalopathy in a pediatric patient following ingestion of delta-8-tetrahydrocannabinol gummies","volume":"22","author":"Akpunonu","year":"2021","journal-title":"Am. J. Case Rep."},{"key":"10.1016\/j.jpba.2022.114987_bib97","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/jat\/bkac007","article-title":"An enhanced LC\u2013MS-MS technique for distinguishing \u03948- and \u03949-tetrahydrocannabinol isomers in blood and urine specimens","volume":"46","author":"Reber","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2022.114987_bib98","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1080\/00032719808005332","article-title":"GC\/MS determination of 11-Nor-9-Carboxy-\u03948-tetrahydrocannabinol in urine from cannabis users","volume":"31","author":"Villamor","year":"1998","journal-title":"Anal. Lett."},{"key":"10.1016\/j.jpba.2022.114987_bib99","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/dta.3190","article-title":"Analytical and medico-legal problems linked to the presence of delta-8-tetrahydrocannabinol (delta-8-THC): Results from urine drug testing in Sweden","volume":"14","author":"Helander","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2022.114987_bib100","unstructured":"S. Vikingsson, R.E. Winecker, E.J. Cone, D.J. Kuntz, B. Dorsey, M. Jacques, M. Senter, R.R. Flegel, E.D. Hayes, Prevalence of Cannabidiol, \u22069- and \u22068-Tetrahydrocannabinol and Metabolites in Workplace Drug Testing Urine Specimens, (n.d.) 9."},{"key":"10.1016\/j.jpba.2022.114987_bib101","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/dta.3159","article-title":"Emergence of the less common cannabinoid \u0394 8 \u2010Tetrahydrocannabinol in a doping sample","volume":"13","author":"Rzeppa","year":"2021","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2022.114987_bib102","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/ptr.6931","article-title":"Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis","volume":"35","author":"P\u00e9rez-Acevedo","year":"2021","journal-title":"Phytother. Res."},{"key":"10.1016\/j.jpba.2022.114987_bib103","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1515\/cclm-2019-0119","article-title":"THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of \u201clight cannabis","volume":"58","author":"Pacifici","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jpba.2022.114987_bib104","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1373\/clinchem.2011.177881","article-title":"Cannabinoid disposition in oral fluid after controlled smoked cannabis","volume":"58","author":"Lee","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2022.114987_bib105","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1373\/clinchem.2016.265371","article-title":"Cannabis edibles: blood and oral fluid cannabinoid pharmacokinetics and evaluation of oral fluid screening devices for predicting \u03949-tetrahydrocannabinol in blood and oral fluid following cannabis brownie administration","volume":"63","author":"Newmeyer","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2022.114987_bib106","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jat\/bkx012","article-title":"Pharmacokinetic profile of oral cannabis in humans: blood and oral fluid disposition and relation to pharmacodynamic outcomes","volume":"41","author":"Vandrey","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2022.114987_bib107","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/dta.2092","article-title":"Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration","volume":"9","author":"Swortwood","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2022.114987_bib108","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1373\/clinchem.2009.141853","article-title":"Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration","volume":"56","author":"Milman","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2022.114987_bib109","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1021\/ac971228g","article-title":"Determination of cannabinoids in water and human saliva by solid-phase microextraction and quadrupole ion trap gas chromatography\/mass spectrometry","volume":"70","author":"Hall","year":"1998","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2022.114987_bib110","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/jat\/bkab074","article-title":"Cannabinoids in oral fluid: limiting potential sources of cannabidiol conversion to \u03949- and \u03948-tetrahydrocannabinol","volume":"45","author":"Coulter","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2022.114987_bib111","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/jat\/bkaa184","article-title":"Quantitation of \u03948-THC, \u03949-THC, cannabidiol and 10 other cannabinoids and metabolites in oral fluid by HPLC\u2013MS-MS","volume":"46","author":"Lin","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2022.114987_bib112","unstructured":"USCC Delta-8 Kit.pdf, (n.d.). \u3008https:\/\/irp.cdn-website.com\/6531d7ca\/files\/uploaded\/USCC%20Delta-8%20Kit.pdf\u3009 (Accessed June 23, 2022)."},{"key":"10.1016\/j.jpba.2022.114987_bib113","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/0024-3205(95)00194-B","article-title":"An efficient new cannabinoid antiemetic in pediatric oncology","volume":"56","author":"Abrahamov","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.jpba.2022.114987_bib114","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s42238-022-00146-9","article-title":"Examining impairment and kinetic patterns associated with recent use of hemp-derived \u03948-tetrahydrocannabinol: case studies","volume":"4","author":"Wurz","year":"2022","journal-title":"J. Cannabis Res."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522004083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522004083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:23:17Z","timestamp":1760001797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708522004083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":114,"alternative-id":["S0731708522004083"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2022.114987","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent challenges and trends in forensic analysis: \u03949-THC isomers pharmacology, toxicology and analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2022.114987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114987"}}